PSI CRO Expands Operations in France With New Paris Location 

PSI CRO, 22 February 2023 – PSI CRO has relocated its office in Paris, France to a new space at 50 Boulevard Rabelais, CS 50021, 94106 Saint-Maur-des-Fosses, Cedex. This is the second time PSI has expanded its operations in France in the past four years, having moved to its previous Paris location in September 2019.

PSI is the sole occupant of the new three-story building located in the center of Saint-Maur-des-Fosses, a commune in Val-de-Marne, the southeastern suburbs of Paris, in the region of Île-de-France. Located near the train station and a bustling downtown hub, the new space positions PSI to continue broadening its operational capabilities and site relationships to support sponsors of pivotal trials.

To celebrate the space’s opening, PSI hosted an open house event to welcome in-area representatives from the community. The inauguration included a red ribbon ceremony, champagne, a buffet, and an official guided tour of the office.

To learn more about the new Paris office or PSI’s full-service CRO capabilities, connect with us here.

About PSI: PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specializes in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors.

Global headquarters are located in Switzerland at 113a Baarerstrasse, Zug 6300. www.psi-cro.com

For Media Inquiries:

Ashley Collins, Marketing Specialist

919-972-9572 |ashley.stufanocollins@psi-cro.com

Share